Pancreatic Hyperamylasemia and Hyperlipasemia Associated With Carfilzomib in Multiple Myeloma.

Pancreatic Hyperamylasemia and Hyperlipasemia Associated With Carfilzomib in Multiple Myeloma. Ann Pharmacother. 2019 May 20;:1060028019851082 Authors: Nakamura Y, Okuda I, Uchida Y, Ito Y, Wakimoto N PMID: 31104468 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31104468?dopt=Abstract

Source: The Annals of Pharmacotherapy - May 19, 2019 Category: Drugs & Pharmacology Authors: Nakamura Y, Okuda I, Uchida Y, Ito Y, Wakimoto N Tags: Ann Pharmacother Source Type: research

More News: Drugs & Pharmacology | Myeloma | Pancreas